Immunocytology in the assessment of patients with painless gross haematuria-Reference-Cited by-同舟云学术

Immunocytology in the assessment of patients with painless gross haematuria

Published:2007-11-13 Issue:0 Volume:0 Page:071115142947012-???
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Schmitz-Dräger Bernd,Tirsar Lenuta A.,Schmitz-Dräger Claudia,Dörsam Joachim,Bismarck Ekkehardt,Ebert Thomas

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.07287.x/fullpdf

Reference15 articles.

1. Evaluation of the patient with hematuria

2. 2 W Oosterlinck, A Van Der Meijden, R Sylvester, G Aus, T Hanus, and J Irani et al.Guidelines on TaT1 (non-muscle invasive) bladder cancer . In. European Association of Urology Guidelines2007 : 3 -17

3. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

4. IMMUNOCYT1

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer;Current Oncology Reports;2024-06-05

2. Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study;Bladder Cancer;2024-03-12

3. Urine biomarkers in bladder cancer — current status and future perspectives;Nature Reviews Urology;2023-05-24

4. Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer;Expert Review of Molecular Diagnostics;2018-05-04

5. Urinary Biomarkers for Diagnosis of Bladder Cancer;Annals of Internal Medicine;2015-12-15